Core Content Review

Acanthosis nigricans (September 2021)

ACE inhibitor and ARB use in diabetes (July 2018)

Acid-base disorders (November 2018)

Acromegaly - 2Qs (May 2023)

Acute gout - 2Qs (May 2021)

Acute pancreatitis (March 2019)

Addisons disease - 2Qs (May 2021)

Adnexal mass in premenopausal women - 2Qs (November 2019)

Arginine vasopressin disorder - 3Qs (May 2025)

Alcohol use disorder (July 2018)

Alcohol use disorder evaluation (July 2018)

Alcohol use disorder - treatment (November 2022)

Alcohol withdrawal - 4Qs (January 2020)

Amenorrhea - Secondary - 2Qs (September 2018)

Amyloidosis (March 2019)

Aspirin therapy and diabetes (May 2019)

Aspirin therapy in diabetics (September 2021)

Atypical antipsychotic medication and diabetes - 2Qs (May 2025)

Bariatric surgery - 2Qs (March 2019)

Bisphosphonates - duration of treatment (May 2024)

Bisphosphonates – adverse effects - 2Qs (May 2025)

Bisphosphonate management (September 2020)

Bone mineral density testing (January 2022)

Cardiovascular kidney metabolic syndrome - 3Qs (May 2025)

Central sleep apnea (January 2023)

Cervical adenopathy (May 2023)

Chronic kidney disease - 2Qs (May 2022)

Chronic pancreatitis - 3Qs (January 2022)

Compression fractures (November 2019)

Congestive heart failure and diabetes - 2Qs (May 2025)

Congenital hypothyroidism - 2Qs (November 2024)

Contraception and neurologic disease - 2Qs (March 2019)

Cushing Syndrome - 2Qs (May 2022)

Diabetes - Journal Club - 5Qs (January 2023)

Diabetes - adding insulin - 2Qs (March 2022)

Diabetes and chronic kidney disease - 3Qs (July 2021)

Diabetes in children (November 2020)

Diabetes - Diagnosis (September 2018)

Diabetes - Individualization of medications - 3Qs (November 2019)

Diabetes - Perioperative management (May 2020)

Diabetic kidney disease - 2Qs (March 2022)

Diabetes - screening in pregnancy (September 2019)

Diabetes - treatment in the elderly (September 2024)

Diabetes - Type 1 in children - 3Qs (September 2020)

Diabetes mellitus - Type 1 Pediatric- 2Qs (January 2020)

Diabetes - Type 2 in children and adolescents - 3Qs (September 2019)

Diabetes mellitus type 2 – prevention - 3Qs (May 2019)

Diabetic autonomic neuropathy - 2Qs (July 2021)

Diabetic foot osteomyelitis - 3Qs (May 2020)

Diabetic ketoacidosis - 4 Qs (July 2021)

Diabetic ketoacidosis and euglycemia - 2Qs (January 2020)

Diabetic retinopathy - 2Qs (January 2022)

Dysmenorrhea - 2Qs (January 2023)

Elevated ammonia level - 2Qs (March 2022)

Factors affecting hemoglobin A1c levels - 2Qs (January 2024)

G6PD deficiency - 5Qs (March 2021)

Galactorrhea (January 2022)

Gastroparesis - 3Qs (September 2024)

Gastroparesis (UPDATED) - 3Qs (May 2020)

Gastroparesis - 3Qs (September 2018)

Gestational diabetes - 4Qs (September 2018)

Gestational diabetes - screening - 2Qs (November 2021)

GLP-1 agonists - 3Qs (July 2023)

Glucagon-like peptide-1 (GLP-1) agonists - 2Qs (July 2024)

Gluten sensitivity - 3Qs (March 2021)

Glycemic control - 3Qs (May 2019)

Gout - 4Qs (September 2020)

Gout prevention - 3Qs (November 2022)

Gout - treatment - 2Qs (July 2023)

Graves disease - 2Qs (July 2020)

Graves disease (September 2018)

Gynecomastia (July 2022)

Gynecomastia - 3Qs (September 2019)

Health maintenance in youth with type 2 diabetes - 3Qs (March 2025)

Heat-related illness -3Qs (January 2021)

Hemoglobin A1c targets - 3Qs (September 2021)

Hemoglobin A1C targets (September 2018)

Hirsutism in women (November 2019)

HIV and long-term comorbidities (July 2022)

Hormone replacement therapy - 3Qs (March 2024)

Hypercalcemia - 5Qs (May 2021)

Hyperglycemia -Medication-induced - 2Qs (September 2019)

Hyperglycemia - Corticosteroid-induced - 3Qs (November 2019)

Hyperosmolar hyperglycemic state - 2Qs (November 2020)

Hyperparathyroidism - 2Qs (July 2020)

Hyperphosphatemia (January 2021)

Hyperphosphatemia - 2Qs (July 2020)

Hyperprolactinemia - 2Qs (January 2020)

Hyperthyroidism - subclinical (May 2021)

Hypertriglyceridemia - 2Qs (July 2021)

Hypertriglyceridemia - 2Qs (May 2024)

Hypertriglyceridemia - 2Qs (November 2018)

Hypoglycemia - Neonatal (September 2019)

Hypogonadism and testosterone therapy - 2Qs (November 2023)

Hypomagnesemia - 2Qs (January 2023)

Hyponatremia - 2Qs (January 2025)

Hyponatremia - 2Qs (May 2019)

Hypoparathyroidism - 2Qs (November 2019)

Hypothyroidism in children - 5Qs (May 2024)

Incretin-based therapy for type 2 diabetes mellitus (July 2018)

Inhalant abuse (January 2023)

Intermittent fasting (January 2021)

Iron overload disorders - 3Qs (May 2021)

Insulin types - 3Qs (July 2021)

Iron overload (November 2024)

Lactic acidosis (September 2022)

Levothyroxine dosing - 3Qs (March 2022)

Levothyroxine drug interactions (January 2022)

Lipid screening in children (November 2019)

Male infertility - 2Qs (January 2025)

Medicare - preventive care for obesity (September 2023)

Medication-related fever (September 2022)

Menstrual migraine - 2Qs (May 2019)

Metabolic dysfunction-associated steatotic liver disease - 2Qs (March 2025)

Metformin (September 2021)

Metformin update - 3Qs (July 2023)

Minimal change disease (November 2019)

Multinodular goiter - 3Qs (January 2021)

Multiple endocrine neoplasia - 4Qs (January 2022)

Myxedema coma (March 2023)

Myxedema coma (May 2022)

Narcolepsy - 3Qs (May 2025)

Natural family planning - 2Qs (May 2025)

Nephrolithiasis in children - 2Qs (July 2021)

Nephrotic syndrome - 2Qs (January 2019)

Nonalcoholic fatty liver disease - 2Qs

Non-motor symptoms of Parkinson disease - 4Qs (May 2022)

Nutrition and mental health - 2Qs (May 2023)

Obesity effect on fertility and pregnancy - 2Qs (November 2022)

Obesity - long-term medication management - 5Qs (March 2024)

Obesity guidelines – pediatrics - 2Qs (May 2025)

Opioid-induced endocrinopathy - 2Qs (November 2021)

Osteoporosis in males - 3Qs (September 2023)

Osteoporosis - secondary (September 2023)

Pancreatitis (November 2022)

Painful diabetic neuropathy - 2Qs (May 2022)

Pancreatitis - 3Qs (July 2022)

Pheochromocytoma - 2Qs (July 2023)

Postpartum thyroiditis (July 2020)

Precocious puberty - 4Qs (May 2024)

Prediabetes - 2Qs (November 2021)

Prediabetes (November 2018)

Prediabetes in adults - 2Qs (May 2020)

Prediabetes in older adults - 3Qs (March 2024)

Pregnancy and obesity (May 2019)

Premature ovarian insufficiency - 3Qs (May 2022)

Premenstrual syndrome and premenstrual dysphoric disorder - 3Qs (May 2022)

Primary hyperparathyroidism - 4Qs (May 2024)

Pseudogout (July 2021)

Restless legs syndrome - 2Qs

Screening for Type 2 Diabetes - 3Qs (January 2022)

Secondary dysmenorrhea (January 2023)

Secondary hyperparathyroidism (July 2023)

Secondary and tertiary hyperparathyroidism - 3Qs (May 2024)

SGLT-2 inhibitors - 3Qs (September 2023)

Short stature in children - 3Qs (July 2024)

SIADH - 2Qs (March 2021)

Sodium-coupled glucose transporter-2 (SGLT2) inhibitors - 2Qs (March 2019)

Statins and diabetes (March 2022)

Subclinical hyperthyroidism (July 2018)

Sulfonylurea overdose - 2Qs (November 2019)

Syndrome of inappropriate antidiuretic hormone (SIADH) - 3Qs (November 2021)

Testing after bisphosphonate therapy for osteoporosis (May 2025)

Thyroid cancer - 2Qs (July 2022)

Thyroid disease in pregnancy - 3Qs (May 2022)

Thyroid medication – dosing - 2Qs (May 2019)

Tranexamic acid (generic, Lysteda) (March 2019)

Transgender health care (March 2019)

Type 2 diabetes and liver disease - 3Qs (September 2024)

Type 2 diabetes in children - medical management - 2Qs (September 2024)

Type 1 diabetes mellitus and bone health - 2Qs (May 2024)

Type 1 diabetes in children - health maintenance - 4Qs (November 2024)

Type 2 diabetes mellitus and bone health - 2Qs (May 2024)

Type 2 diabetes mellitus - initial management - 3Qs (July 2020)

Type 2 diabetes in youths - 2Qs (July 2024)

Understanding lipid recommendations - 2Qs (September 2018)

Uterine bleeding - Abnormal (September 2018)

Uterine bleeding in the adolescent - Abnormal - 3Qs (September 2018)

Vitamin B12 deficiency (November 2019)

Vitamin D - 2Qs (January 2024)

Wilson's disease (March 2019)